Document is current
Any future updates will be listed below
-
Authors
Łabuz, Grzegorz
Yildirim, Timur M.
Auffarth, Gerd U. http://orcid.org/0000-0002-6927-5251
Son, Hyeck-Soo
Khoramnia, Ramin
-
Funding
Funding for this research was provided by:
Klaus Tschira Stiftung (NA)
- License Information
-
More Information
Article History
Received: 12 September 2020
Accepted: 16 March 2021
First Online: 22 April 2021
Declarations
:
: Not applicable.
: G. Auffarth reports grants, personal fees, non-financial support and consulting fees from Johnson&Johnson and Alcon, grants, personal fees and non-financial support from Carl Zeiss Meditec, Hoya, Kowa, Oculentis/Teleon, Rayner, Santen, Sifi, Ursapharm, grants and personal fees from Biotech, Oculus, EyeYon grants from Acufocus, Anew, Contamac, Glaukos, Physiol, Rheacell, outside the submitted work. R. Khoramnia reports grants, personal fees and non-financial support from Alimera, Alcon, Bayer, Johnson&Johnson, Hoya, Novartis, Physiol, Rayner and Roche, grants from Chengdu Kanghong, personal fees and non-financial support from Allergan, Kowa, Oculentis/Teleon, Oculus, Santen, and Acufocus, outside the submitted work. H. Son reports non-financial support from Alcon outside the submitted work. G. Łabuz and T. Yildirim have nothing to disclose.
